Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Insilico's Chemistry42 AI system integrated into UCB's drug discovery programs 2021-03-09 22:00
Clarivate Drugs to Watch Report Highlights Four Likely Blockbusters Among Drugs Launching in 2021 2021-03-09 16:00
Entire industrial chain resources of advanced medical equipment are lining up at Medtec China 2021 2021-03-09 09:30
FASN Inhibitor ASC40 Demonstrates Positive Phase 2 Topline Clinical Results from China Cohort of Patients with NASH 2021-03-09 08:30
AMD Telemed Applauded by Frost & Sullivan for Its Modular Engage N' Solution that Supports Patient Needs by Acuity Level 2021-03-09 01:12
Wugen Announces Exclusive Partnership Agreement With Alpha Biopharma in Asia For Cell Therapies to Treat Cancer 2021-03-08 22:00
Patients Win When Support Is Personalized: New Study From Atlantis Healthcare Shows Treatment Persistence and Adherence Improved by 38% 2021-03-08 08:48
Cipla Gulf Expands Partnership with Alvotech for Commercialization of Biosimilars in Australia and New Zealand 2021-03-02 22:05
Merck and GPHL Collaborate on Business Innovation and Development in the Greater Bay Area 2021-03-02 18:12
Oscotec and Beactica Therapeutics announce license and collaboration agreement to develop new cancer drug 2021-03-02 15:21
INOVIO Announces Positive Results from REVEAL 1, a Phase 3 Pivotal Trial Evaluating VGX-3100, its DNA-based HPV Immunotherapy for the Treatment of High-grade Precancerous Cervical Dysplasia Caused by HPV-16 and/or HPV-18 2021-03-02 05:05
Everest Medicines Announces Selection as a Constituent of Certain Indexes of Hang Seng Indexes Company Limited 2021-03-01 12:36
Sciwind's Investigational New Drug Approved for NASH Trial 2021-03-01 09:00
Innovent Announces First Patient Outside China Dosed in the Phase 1 Clinical Trial of Anti-CD47/PD-L1 Bispecific Antibody 2021-03-01 08:23
Sirtex Medical receives positive recommendation from National Institute for Health and Care Excellence (NICE) for selective internal radiation therapy (SIRT) using SIR-Spheres® 2021-02-26 23:37
Debiopharm And Genome & Company Join Forces To Create New Highly Specific Therapies For Cancer Patients 2021-02-26 19:14
Harbour BioMed Announces NMPA Approval of IND for Combination Therapy of Next Gen Anti-CTLA-4 Antibody for Treatment of NSCLC and Solid Tumors 2021-02-26 10:16
New Data Presented at ACTRIMS Forum 2021 Indicate MAVENCLAD®-treated RMS Patients Mount Protective Antibody Response to Common Vaccines 2021-02-25 21:00
Gannex Announces U.S. IND Approval and Initiation of Global Development of THR-β Agonist ASC41 for NASH 2021-02-25 08:30
WuXi Biologics Wins 2021 CMO Leadership Awards in All Six Core Categories 2021-02-25 08:00
1 133 134 135 136 137 235